Literature DB >> 20430954

Lysosomal storage disease: revealing lysosomal function and physiology.

Emma J Parkinson-Lawrence1, Tetyana Shandala, Mark Prodoehl, Revecca Plew, Glenn N Borlace, Doug A Brooks.   

Abstract

The discovery over five decades ago of the lysosome, as a degradative organelle and its dysfunction in lysosomal storage disorder patients, was both insightful and simple in concept. Here, we review some of the history and pathophysiology of lysosomal storage disorders to show how they have impacted on our knowledge of lysosomal biology. Although a significant amount of information has been accrued on the molecular genetics and biochemistry of lysosomal storage disorders, we still do not fully understand the mechanistic link between the storage material and disease pathogenesis. However, the accumulation of undegraded substrate(s) can disrupt other lysosomal degradation processes, vesicular traffic, and lysosomal biogenesis to evoke the diverse pathophysiology that is evident in this complex set of disorders.

Entities:  

Mesh:

Year:  2010        PMID: 20430954     DOI: 10.1152/physiol.00041.2009

Source DB:  PubMed          Journal:  Physiology (Bethesda)        ISSN: 1548-9221


  65 in total

Review 1.  Lysosomal physiology.

Authors:  Haoxing Xu; Dejian Ren
Journal:  Annu Rev Physiol       Date:  2015       Impact factor: 19.318

Review 2.  Macrophage-related diseases of the gut: a pathologist's perspective.

Authors:  Xavier Sagaert; Thomas Tousseyn; Gert De Hertogh; Karel Geboes
Journal:  Virchows Arch       Date:  2012-05-11       Impact factor: 4.064

3.  Identification of a single aspartate residue critical for both fast and slow calcium-dependent inactivation of the human TRPML1 channel.

Authors:  Guangyan Wu; Xue Yang; Yuequan Shen
Journal:  J Biol Chem       Date:  2018-06-08       Impact factor: 5.157

4.  δ-Tocopherol Effect on Endocytosis and Its Combination with Enzyme Replacement Therapy for Lysosomal Disorders: A New Type of Drug Interaction?

Authors:  Rachel L Manthe; Jeffrey A Rappaport; Yan Long; Melani Solomon; Vinay Veluvolu; Michael Hildreth; Dencho Gugutkov; Juan Marugan; Wei Zheng; Silvia Muro
Journal:  J Pharmacol Exp Ther       Date:  2019-05-17       Impact factor: 4.030

5.  An improved purification method for the lysosomal storage disease protein β-glucuronidase produced in CHO cells.

Authors:  Erica J Fratz-Berilla; Stephanie A Ketcham; Hamideh Parhiz; Muhammad Ashraf; Chikkathur N Madhavarao
Journal:  Protein Expr Purif       Date:  2017-07-19       Impact factor: 1.650

6.  Alteration of lysosome fusion and low-grade inflammation mediated by super-low-dose endotoxin.

Authors:  Bianca Baker; Shuo Geng; Keqiang Chen; Na Diao; Ruoxi Yuan; Xiguang Xu; Sean Dougherty; Caroline Stephenson; Huabao Xiong; Hong Wei Chu; Liwu Li
Journal:  J Biol Chem       Date:  2015-01-13       Impact factor: 5.157

7.  ICAM-1 targeting, intracellular trafficking, and functional activity of polymer nanocarriers coated with a fibrinogen-derived peptide for lysosomal enzyme replacement.

Authors:  Carmen Garnacho; Silvia Muro
Journal:  J Drug Target       Date:  2017-07-14       Impact factor: 5.121

8.  Therapeutic approaches for lysosomal storage diseases.

Authors:  Gregory M Pastores
Journal:  Ther Adv Endocrinol Metab       Date:  2010-08       Impact factor: 3.565

9.  Retinal degeneration in mucopolysaccharidose type II.

Authors:  F Liang; I Audo; J A Sahel; M Paques
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-12-04       Impact factor: 3.117

10.  Lysosome imaging in cancer cells by pyrene-benzothiazolium dyes: An alternative imaging approach for LAMP-1 expression based visualization methods to avoid background interference.

Authors:  Chathura S Abeywickrama; Kaveesha J Wijesinghe; Robert V Stahelin; Yi Pang
Journal:  Bioorg Chem       Date:  2019-07-24       Impact factor: 5.275

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.